InvestorsHub Logo

jmh0602

04/11/17 5:20 PM

#3045 RE: NeverSettle #3044

Nov 2, 2014 the option agreement was announced and its Galecto, not GALT.

Chess Master

04/11/17 11:50 PM

#3051 RE: NeverSettle #3044

I think what you want to say is that this article was written 30 days ago which means that BMY has only 30 days left to complete the acquisition. If complete that acquisition justifies a premium price for GALT being the only publically traded Galectin Inhibitor.